Post-market validation of a further two serological assays for COVID-19 – updated report

This report present results of post-market validation of a further 2 serological assays for the detection of SARS-CoV-2 antibodies.

Downloads

Post-market validation of a further two serological assays for COVID-19

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Report
Audience:
Health sector
Language:
English
Description:

The Doherty Institute has evaluated 15 serology-based point of care tests.

The evaluation is part of a review of these tests by the Therapeutic Goods Administration (TGA).

These findings will inform the need for TGA to undertake any post-market action.

This could include changes to the instructions for use to include more information about the limitations of the tests.

Further information is on the TGA’s website, post-market evaluation of serology-based point of care tests.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.